ANI Pharmaceuticals
ANIP • NASDAQ
ANI Pharmaceuticals is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Nikhil Lalwani, with a market cap of $1.8B.
Market Cap$1.8B
Employees642.0
CEONikhil Lalwani
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 8, 2026 · In 3 weeksQ1 2026
Financials
ANI Pharmaceuticals FAQ
Common questions about ANI Pharmaceuticals
ANI Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 8, 2026. Analysts estimate revenue of $212.7M.
ANI Pharmaceuticals has approximately 642 employees.